OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2026)

OptimizeRx has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $5.7 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 49.37% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (up 49.37% YoY) and the FY2025 annual result came in at $5.7 million, down 52.24% from the prior year.
• Non-Current Deferred Tax Liability eased to $5.7 million in Q1 2026 per OPRX's latest filing, from $5.7 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $11.9 million in Q4 2024 and troughed at $2.3 million in Q4 2022.
• A 5-year average of $4.8 million and a median of $4.3 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability jumped 175.4% in 2024, then plunged 52.24% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $2.3 million in 2022, then soared by 86.14% to $4.3 million in 2023, then surged by 175.4% to $11.9 million in 2024, then slumped by 52.24% to $5.7 million in 2025, then declined by 0.88% to $5.7 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $5.7 million, $5.7 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.